Non-alcoholic fatty liver disease ⇒ Steatohepatitis {40000151}
Definition: | Non-alcoholic fatty liver disease |
---|---|
Class: |
Other Terms: | NAFLD, NAFLD, Nonalcoholic Steatohepatitis, NASH |
---|---|
Authoring date: | 2020-09-06 |
ICD: | [ ] |
---|---|
Category: | Gastroenterologic |
MedDra ID: | 10082249 |
MedDra Level: | pt |
Notes
- Low levels of Parabacteroides distasonis lead to the development of NASH and increase cardiovascular risk. (1)
- Decreased levels of Prevotella might be detrimental for adults with NAFLD. (2)
Shared Notes
- [1.17]
- Metagenome-based gut microbiome panel can accurately diagnose advanced fibrosis
Common References
- [1.1] Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease [2020] [80001417] [Liver International]
- [1.2] Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease [2019] [80001063] [Gastroenterology]
- [1.3] Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease [2015] [80000572] [Scientific Reports]
- [1.4] Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach [2017] [80000626] [Hepatology]
- [1.5] The severity of Nonalcoholic Fatty Liver Disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota [2016] [80000625] [Hepatology]
- [1.6] Fecal and blood microbiota profiles and presences of nonalcoholic fatty liver disease in obese versus lean subjects [2019] [80001021] [PLOS ONE]
- [1.7] Changes of intestinal bacterial microbiota in coronary hearth disease complicated with nonalcoholic fatty liver disease [2019] [80001292] [BMC Genomics]
- [1.8] Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease [2013] [80001027] [Clinical Gastroenterology and Hepatology]
- [1.9] A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease [2019] [80000948] [Nature communications]
- [1.10] Metagenome of gut microbiota of children with nonalcoholic fatty liver disease [2019] [80001279] [Frontiers in Pediatrics]
- [1.11] Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance [2018] [80000685] [Scientific Reports]
- [1.12] Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as healthy players? [2018] [80000695] [Archives of Medical Science: AMS]
- [1.13] An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity [2019] [80000904] [Revista espanola de enfermedades digestivas]
- [1.14] Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease. [2016] [80000569] [Scientific Reports]
- [1.15] Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study [2019] [80001164] [Hepatology International]
- [1.16] A microbial signature identifies advanced fibrosis in patients with chronic liver disease mainly due to NAFLD [2020] [80001341] [Scientific Reports]
- [1.17] Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease [2017] [Research] [80001561] [Cell Metabolism]